Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Weiyan Tao"'
Autor:
Yong Yang, Qingyi Zhu, Jin-Rong Zhou, Jinsong Bian, Weiyan Tao, Yan Cheng, Jingjing Duan, Xiaofang Gao, Wanli Ye, Shijia Du, Xianjing Li, Zhuo Wang, Zhen Chen, Guangjiang Shi, Zhili Zhao, Yan Li, Linjun You, Hongxi Wu
Disruption of IRF8 in PCa cells affects cell growth in vitro and tumorigenesis in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c8ae95d749b67c0638945ef3d73ad24
https://doi.org/10.1158/0008-5472.22424616
https://doi.org/10.1158/0008-5472.22424616
Autor:
Yong Yang, Qingyi Zhu, Jin-Rong Zhou, Jinsong Bian, Weiyan Tao, Yan Cheng, Jingjing Duan, Xiaofang Gao, Wanli Ye, Shijia Du, Xianjing Li, Zhuo Wang, Zhen Chen, Guangjiang Shi, Zhili Zhao, Yan Li, Linjun You, Hongxi Wu
IRF8 expression is regulated by the androgen-AR pathway.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6be068486fc62336eb377c08b59563
https://doi.org/10.1158/0008-5472.22424619.v1
https://doi.org/10.1158/0008-5472.22424619.v1
Autor:
Yong Yang, Qingyi Zhu, Jin-Rong Zhou, Jinsong Bian, Weiyan Tao, Yan Cheng, Jingjing Duan, Xiaofang Gao, Wanli Ye, Shijia Du, Xianjing Li, Zhuo Wang, Zhen Chen, Guangjiang Shi, Zhili Zhao, Yan Li, Linjun You, Hongxi Wu
Figure S4. IRF8 reduces AR protein levels and activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490d521a56ecf392de4a5493960a51d7
https://doi.org/10.1158/0008-5472.22424613
https://doi.org/10.1158/0008-5472.22424613
Autor:
Yong Yang, Qingyi Zhu, Jin-Rong Zhou, Jinsong Bian, Weiyan Tao, Yan Cheng, Jingjing Duan, Xiaofang Gao, Wanli Ye, Shijia Du, Xianjing Li, Zhuo Wang, Zhen Chen, Guangjiang Shi, Zhili Zhao, Yan Li, Linjun You, Hongxi Wu
IRF8 was not frequently mutated and methylated in clinical PCa tissues and cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d01c2e654ccce805b4d90bd8e752f0
https://doi.org/10.1158/0008-5472.22424598.v1
https://doi.org/10.1158/0008-5472.22424598.v1
Autor:
Yong Yang, Qingyi Zhu, Jin-Rong Zhou, Jinsong Bian, Weiyan Tao, Yan Cheng, Jingjing Duan, Xiaofang Gao, Wanli Ye, Shijia Du, Xianjing Li, Zhuo Wang, Zhen Chen, Guangjiang Shi, Zhili Zhao, Yan Li, Linjun You, Hongxi Wu
IFNα enhances ENZ sensitivity targeting the AR/IRF8 axis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7431e48c56ff4a5f6b3440e7a84c6cf3
https://doi.org/10.1158/0008-5472.22424601
https://doi.org/10.1158/0008-5472.22424601
Autor:
Yong Yang, Qingyi Zhu, Jin-Rong Zhou, Jinsong Bian, Weiyan Tao, Yan Cheng, Jingjing Duan, Xiaofang Gao, Wanli Ye, Shijia Du, Xianjing Li, Zhuo Wang, Zhen Chen, Guangjiang Shi, Zhili Zhao, Yan Li, Linjun You, Hongxi Wu
In incurable castration-resistant prostate cancer (CRPC), resistance to the novel androgen receptor (AR) antagonist enzalutamide is driven mainly by AR overexpression. Here we report that the expression of interferon regulatory factor 8 (IRF8) is inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e886effb330b35da8ff4d89921debbc0
https://doi.org/10.1158/0008-5472.c.6511821.v1
https://doi.org/10.1158/0008-5472.c.6511821.v1
Autor:
Xiaofang Gao, Jingjing Duan, Yong Yang, Jin-Song Bian, Guangjiang Shi, Zhen Chen, Zhili Zhao, Zhuo Wang, Yan Li, Shijia Du, Yan Cheng, Weiyan Tao, Qingyi Zhu, Linjun You, Xianjing Li, Jin-Rong Zhou, Hongxi Wu, Wanli Ye
Publikováno v:
Cancer Res
In incurable castration-resistant prostate cancer (CRPC), resistance to the novel androgen receptor (AR) antagonist enzalutamide is driven mainly by AR overexpression. Here we report that the expression of interferon regulatory factor 8 (IRF8) is inc
Autor:
Fei Quan, Dan-Dan Zhao, Qiuhua Cao, Zhisen Yang, Cheng Chen, Xin Chen, Zhen Chen, Weiyan Tao, Rui Sun, Sen Zhao, Duowei Wang, He Lihua, Jiani Li, Ran Qi, Kaiyong Hu, Yuan Lu, Yong Yang, Dong Ding, Xinghua Gao, Yan Luo
Publikováno v:
European journal of pharmacology. 854
Colitis-associated cancer (CAC) has a close relationship with ulcerative colitis (UC). Therapeutic effect of Schisandrin B (SchB) on UC and CAC remains largely unknown. We investigated the preventative effect of SchB on the dextran sulphate sodium (D